MDS/MPN facts Flashcards

1
Q

Gene rearrangements in M/L neoplasms with eosinophilia

A

PDGFRA, PDGFRB, FGFR1, JAK2, FLT3, ETV6::ABL1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Clonal disorder in eosinophilia workup %

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MLN- TK with FGFR1 rearrangement Tx

A

Pemigatinib
FGFR2 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MLN- TK with PDGFRA/PDGFRB rearrangement Tx

A

Imatinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MLN- TK with ETV6::ABL1 rearrangement Tx

A

Dasatinib
Nilotinib
Imatinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Diagnosis of MDS/MPN-U

A

not meeting criteria for MDS, MPN
clinical features of MDS with WBC> 13 and PLT>45O

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Blastic plasmacytoid dendritic cell neoplasm

A

aggressive neoplasm with skin lesions
may develop to AML/CMML
Tagraxofusp- anti IL3 (conjugated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tagraxofusp

A

anti IL3 (conjugated)
Tx of BPDCN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CNL Tx

A

Hydrea
Ruxo
Dasatinib in some cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

aCML BMB findings

A

Neutrophilia, Left shift, Dysgranulopoiesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

aCML diagnosis

A

WBC> 13K
>10% circulating immature cells
balsts< 20%
Prominent dysgranulopoiesis
monocytes, eosinophiles< 10%
BCR:ABL1, and other driving mutations negative
ASXL1 and SETBP1 positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

most common cytogenetic abnormalities in aCML

A

+8
-7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

most common mutations in aCML

A

ASXL1 (60–90%)
ETKN1
TET2
SRSF2
SETBP1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Prognostic risk factors for aCML

A

age> 67
Hb< 10
TET2 mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

median OS for aCML

A

10-30 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

incidence of aCML

A

1-2% of CML

17
Q

MDS/MPN-NOS

A

diagnosis not meeting any MPN
mutation profile can devide to:
CMML like
aCML like
MDS/MPN-ring sideroblasts-thrombocytosis like
p53 +
and other
prognosis and Tx is based on genetic profiling

18
Q

Langerhans cell histiocytosis catagorization

A

Single system
Multisystem

19
Q

Single system Langerhans cell histiocytosis

A

Bone- most common
Skin
Lymph nodes
Lung

20
Q

Tx of bone involvement of LCH

A

Resection/radiation/steroid injection

21
Q

Tx of skin involvement of LCH

A

Topical steroids
Nitrogen mustard cream
phototherapy

22
Q

Tx of lung involvement of LCH

A

Smoking cessation
Prednisone, vinblastine, MTX
Immunosuppressive agents.

23
Q

Erdheim-Chester disease clinical manifestations

A

Osteosclerosis of
the legs
Fibrosis of skeleton, retroperitoneum,
skin, CNS, heart, lungs, and less commonly, lymph nodes,
liver, and spleen

24
Q

Tx of Erdheim-Chester disease

A

Interferon-a

25
Q

Rosai-Dorfman disease

A

Sinus histiocytosis with massive lymphadenopathy

26
Q

HLH criteria

A

Fever
Hemophagocytosis on BM
Splenomegaly
Cytopenias
High IL2
Ferritin
Triglycerides
Low NK

27
Q

MDS-MPN NOS criteria

A

MDS Features
with WBC>13/ PLT>450